Table 1 Socio demographics and clinical characteristics at cohort entry for total of analyzed subjects and deceased subjects
Total | Deaths | ||||
|---|---|---|---|---|---|
py | n | % | n | % | |
Total | 28,743 | 8,214 | 100 | 294 | 100 |
Gender | |||||
Males | 21,903 | 6,412 | 78.0 | 237 | 80.6 |
Females | 6,840 | 1,802 | 22.0 | 57 | 19.4 |
Age at cohort entry (years) | |||||
20–29 | 6,945 | 2,064 | 25.1 | 34 | 11.6 |
30–39 | 13,778 | 3,722 | 45.3 | 145 | 49.3 |
40–49 | 5,584 | 1,705 | 13.1 | 71 | 24.1 |
> = 50 | 2,436 | 723 | 8.8 | 44 | 15.0 |
Median age (IQR) | 35.0 (30.2–41.0) | 37.7(33.5–44.5) | |||
Category of transmission | |||||
IDUs | 8,515 | 2,050 | 25.0 | 177 | 60.2 |
MSM | 9,994 | 3,255 | 39.6 | 41 | 14.0 |
Heterosexual | 8,909 | 2,524 | 30.7 | 67 | 22.8 |
Others/Unknown | 1,325 | 385 | 4.7 | 9 | 3.0 |
AIDS | |||||
No | 22,255 | 6,542 | 79.6 | 144 | 49.0 |
AIDS before entry | 3,667 | 994 | 12.1 | 72 | 24.5 |
AIDS after entry | 2,821 | 678 | 8.3 | 78 | 26.5 |
CD4 count at entry (cel/mm3) | |||||
<200 | 7,525 | 2,217 | 27.0 | 141 | 48.0 |
200–349 | 5,191 | 1,567 | 19.1 | 39 | 13.3 |
> = 350 | 12,366 | 3,744 | 45.6 | 64 | 21.8 |
Unknown | 3,661 | 686 | 8.4 | 50 | 17.0 |
Median (IQR) | 350 (170–552) | 154 (66–390) | |||
HIV viral load (copies/ml) | |||||
<20.000 | 8,748 | 2,769 | 33.7 | 61 | 20.7 |
20.000-100.000 | 7,141 | 2,202 | 26.8 | 65 | 22.1 |
>100.000 | 7,181 | 2,196 | 26.7 | 89 | 30.3 |
Unknown | 5,673 | 1,047 | 12.8 | 79 | 26.9 |
Median (IQR) | 39,810 (7,520–135,988) | 78,200 (17,335–230,000) | |||
Cohorts | |||||
CoRIS (2004–2008) | 18,447 | 5,761 | 70.1 | 137 | 46.6 |
CoRIS-MD (1997–2003) | 10,296 | 2,453 | 29.9 | 157 | 53.4 |
HCV test | |||||
Negative | 18,332 | 5,673 | 69.1 | 96 | 32.6 |
Positive | 10,411 | 2,541 | 30.9 | 198 | 67.4 |
Antiretroviral treatment during follow-up | |||||
No | 9,992 | 1,948 | 23.7 | 63 | 21.4 |
Yes | 18,751 | 6,266 | 76.3 | 231 | 78.6 |